ArticleJournal of nephrology2025
The evolution of consultation practices with general practitioners and nephrologists for patients with chronic kidney disease before and after the COVID-19 pandemic in France.
Article in Journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic led to concerns about disruptions in the follow-up of chronic diseases, including chronic kidney disease (CKD). Here, we assessed the COVID-19 pandemic impact on healthcare use by patients with CKD in France.
methodsWe used the French National Health Data System (SDNS) that contains data on outpatient and inpatient healthcare of the whole French population. Using a validated algorithm, we identified two CKD cohorts based on their healthcare utilization: (i) the 2019 cohort (pandemic-exposed) and (ii) the 2017 cohort (comparator). We followed these cohorts for 2 years and compared consultations (in-person and teleconsultation) with a general practitioner (GP) and a nephrologist and all-cause hospitalizations (excluding COVID-19 as primary diagnosis). We stratified comparisons by age group and sex.
resultsWe identified 4,866,096 individuals with CKD in 2017 and 5,089,706 in 2019. During the first year of follow-up, 95.2% and 6.4% of patients in the 2017 cohort had at least one consultation with a GP and with a nephrologist, respectively, versus 94% and 6.3% in the 2019 cohort. Teleconsultations compensated for the reduction of in-person GP and nephrologist consultations throughout the lockdown periods in 2020 and 2021 (40.5% of patients in the 2019 cohort had at least one in-person consultation and 52.5% an in-person or tele-consultation with a GP). Hospitalizations ≥ 24 h decreased in 2020 and 2021 (-10%).
conclusionsIn France, outpatient care for CKD was maintained during the 2 years following the COVID-19 pandemic, thanks to teleconsultations. The persistently lower inpatient care utilization warrants further investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.